Loading...

Phoenix Biotech Acquisition Corp.

PBAXNASDAQ
Financial Services
Shell Companies
$5.85
$0.37(6.75%)

Phoenix Biotech Acquisition Corp. (PBAX) Stock Competitors & Peer Comparison

See (PBAX) competitors and their performances in Stock Market.

Peer Comparison Table: Shell Companies Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PBAX$5.85+6.75%36.5M-16.71-$0.35N/A
CCIV$24.25+5.90%44.4BN/AN/AN/A
SYM$53.75+5.99%32B-659.37-$0.08N/A
PSACU$17.08+0.35%12B-108.79-$0.16N/A
RTPY$9.91-0.30%11.6BN/AN/AN/A
LVRAW$0.04+0.00%11.5BN/AN/AN/A
CMLFU$13.00-4.55%10.3B-1444.44-$0.01N/A
PSAC$13.78-0.36%9.7BN/AN/AN/A
GRSVU$11.39+3.36%6.8BN/AN/AN/A
APSG$7.39-25.88%6.3B36.95$0.20N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PBAX vs CCIV Comparison July 2025

PBAX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBAX stands at 36.5M. In comparison, CCIV has a market cap of 44.4B. Regarding current trading prices, PBAX is priced at $5.85, while CCIV trades at $24.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBAX currently has a P/E ratio of -16.71, whereas CCIV's P/E ratio is N/A. In terms of profitability, PBAX's ROE is +10.03%, compared to CCIV's ROE of -0.69%. Regarding short-term risk, PBAX is more volatile compared to CCIV. This indicates potentially higher risk in terms of short-term price fluctuations for PBAX.Check CCIV's competition here

Stock price comparison of stocks in the Financial Services Sector

Loading...

Frequently Asked Questions

;